Get the Stockscreener App
2.54
5.93%
-0.16
After Hours:
2.45
-0.09
-3.54%
Icad Inc stock is traded at $2.54, with a volume of 466.71K.
It is down -5.93% in the last 24 hours and up +4.96% over the past month.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
See More
Previous Close:
$2.70
Open:
$2.7
24h Volume:
466.71K
Relative Volume:
1.02
Market Cap:
$66.94M
Revenue:
$18.94M
Net Income/Loss:
$-2.71M
P/E Ratio:
-18.14
EPS:
-0.14
Net Cash Flow:
$-4.92M
1W Performance:
-23.49%
1M Performance:
+4.96%
6M Performance:
+49.41%
1Y Performance:
+80.14%
1-Day Range:
$2.47
$2.79
1-Week Range:
$2.47
$3.28
52-Week Range:
$1.18
$3.78
Icad Inc Stock (ICAD) Company Profile
Name
Icad Inc
Sector
Industry
Phone
603-882-5200
Address
98 SPIT BROOK ROAD, SUITE 100, NASHUA, NH
Compare ICAD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICAD
Icad Inc
|
2.54 | 66.94M | 18.94M | -2.71M | -4.92M | -0.14 |
|
ABT
Abbott Laboratories
|
134.95 | 234.06B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.39 | 154.06B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
387.92 | 148.02B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.17 | 115.71B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.76 | 42.91B | 5.72B | 4.17B | 490.10M | 6.97 |
Icad Inc Stock (ICAD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-18-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-22-21 | Initiated | Guggenheim | Buy |
| Mar-23-21 | Initiated | BTIG Research | Buy |
| Feb-26-21 | Initiated | Oppenheimer | Outperform |
| Jan-29-21 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-03-20 | Initiated | B. Riley Securities | Buy |
| Feb-05-20 | Initiated | JMP Securities | Mkt Outperform |
| Jan-09-20 | Initiated | Lake Street | Buy |
| Dec-09-08 | Reiterated | Canaccord Adams | Buy |
| Aug-01-08 | Reiterated | MDB Capital Group | Buy |
| May-14-08 | Reiterated | Canaccord Adams | Buy |
| Feb-14-08 | Initiated | Sun Trust Rbsn Humphrey | Buy |
| Jan-24-07 | Reiterated | Dawson James | Speculative Buy |
View All
Icad Inc Stock (ICAD) Latest News
iCAD, Inc. (ICAD): A Bull Case Theory - Insider Monkey
iCAD, Inc. (ICAD) to Showcase AI-Powered Breast Health Innovations at ECR 2025 - Insider Monkey
9 AI News and Ratings on Wall Street’s Radar - Insider Monkey
iCAD To Showcase Five AI-Powered Research Presentations - GlobeNewswire
iCAD Shares Unchanged Ahead of Presentations - Baystreet.ca
Earnings call transcript: ICAD Q4 2024 shows strategic resilience By Investing.com - Investing.com Canada
Can AI Transform Breast Cancer Detection? iCAD's Revolutionary Research Answers Key Questions - StockTitan
iCAD (NASDAQ:ICAD) Shares Pass Above 200 Day Moving AverageWhat's Next? - MarketBeat
117,000 Shares in iCAD, Inc. (NASDAQ:ICAD) Acquired by Summit Trail Advisors LLC - MarketBeat
iCAD (NASDAQ:ICAD) Rating Lowered to “Sell” at StockNews.com - Defense World
iCAD (NASDAQ:ICAD) Lowered to Sell Rating by StockNews.com - MarketBeat
After Falling -15.24% During The Past Week, Should You Still Buy Oruka Therapeutics Inc (NASDAQ: ORKA)? - Marketing Sentinel
Icad Inc (NASDAQ:ICAD) Up 63.91% Since 52-Week Low; YTD Rose 78.69% – Here’s What You Need To Do - Marketing Sentinel
Now Is The Time To Build A Position In Health In Tech Inc (NASDAQ:HIT) - Marketing Sentinel
After Sinking 6.37% During Past Week, Is GRAIL Inc (NASDAQ: GRAL) Still A Buy? - Marketing Sentinel
Dominari Holdings Inc (NASDAQ: DOMH) Stock Gained 177.59% Over A Month – Any Room To Run? - Marketing Sentinel
Intelligent Bio Solutions Inc (NASDAQ: INBS): Can A Stock Be 51.43% Higher Year-To-Date And Still Be A Loser? - Marketing Sentinel
Reliance Global Group Inc (NASDAQ: RELI) Stock Dropped -28.15% Over A Month – Any Room To Run? - Marketing Sentinel
Sobr Safe Inc (NASDAQ: SOBR) Stock Has Dropped -22.04% Over The Month – Is There Room For Growth? - Marketing Sentinel
ScanTech AI Systems Inc (NASDAQ: STAI) Gain Of 9.66% Compared To 52-Week Low; YTD Fall -84.49% – What Should You Do Now? – Marketing Sentinel - Marketing Sentinel
Now Is The Time To Build A Position In SolarBank Corporation (NASDAQ:SUUN) - Marketing Sentinel
Icad Inc (ICAD) deserves closer scrutiny - US Post News
The Psychology of Icad Inc Inc. (ICAD) Price Performance: Understanding Market Sentiment - The InvestChronicle
Is Oragenics Inc (AMEX: OGEN) Stock Ready For A Higher Run In Its Share Price? - Marketing Sentinel
Why iCAD Inc (ICAD) Is Skyrocketing So Far In 2025 - Yahoo Finance
Short Interest in iCAD, Inc. (NASDAQ:ICAD) Decreases By 14.5% - MarketBeat
Graphjet Technology (NASDAQ:GTI) Stock Plunged -64.80% So Far In 2025, What Analysts Expect Next? - Marketing Sentinel
Earnings call transcript: iCAD Q3 2024 sees revenue rise, SaaS shift - MSN
StockNews.com Downgrades iCAD (NASDAQ:ICAD) to Sell - MarketBeat
Now Is The Time To Build A Position In Sobr Safe Inc (NASDAQ:SOBR) - Marketing Sentinel
Why ICAD Stock Is Climbing Today - MSN
iCAD, Inc. Pre-Announces Estimated Q4 2024 Revenue - Defense World
iCAD stock soars to 52-week high, reaching $2.67 amid robust gains - MSN
After Leaping 46% iCAD, Inc. (NASDAQ:ICAD) Shares Are Not Flying Under The Radar - Simply Wall St
iCAD stock soars to 52-week high, reaching $2.67 amid robust gains By Investing.com - Investing.com South Africa
iCAD Shares Climb After 4Q Sales Guidance Beats Expectations - MarketWatch
ICAD, Inc. Provides Earnings Guidance for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com
iCAD Pre-Announces Estimated Q4 2024 Revenue - GlobeNewswire
iCAD Reports Strong Q4: 106 Deals Closed, T-ARR Grows 11% to $9.8M - StockTitan
A -292.16% Or Greater Growth Is Projected For Vor Biopharma Inc (NASDAQ: VOR) - Marketing Sentinel
Barfresh Food Group And 2 Other US Penny Stocks To Watch - Simply Wall St
Zacks Market Edge Highlights: FiscalNote, and iCAD - Yahoo Finance
iCAD, Inc. (NASDAQ:ICAD) Sees Significant Decline in Short Interest - MarketBeat
Now Is The Time To Build A Position In Pony AI Inc. ADR (NASDAQ:PONY) - Marketing Sentinel
Discover the AI Stocks Under $5 That Investors Are Talking About - Kuhinje EWE Daily
It’s Worth A Gamble To Have A Position In DatChat Inc (NASDAQ: DATS) At $5.85. - Marketing Sentinel
2 AI Stocks Under $5 - Yahoo Finance
Now Is The Time To Build A Position In MGO Global Inc (NASDAQ:MGOL) - Marketing Sentinel
Strategic Acquisitions by Hologic and iCAD Shape Future of CAD Market - openPR
Now Is The Time To Build A Position In Signing Day Sports Inc (AMEX:SGN) - Marketing Sentinel
Icad Inc Stock (ICAD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):